Sharon Mu
Publications by Year
Research Areas
Platelet Disorders and Treatments, Asthma and respiratory diseases, Gut microbiota and health, Computational Drug Discovery Methods, Synthesis and biological activity
Most-Cited Works
- → WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major Infection(2001)408 cited
- → The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity(2004)246 cited
- → Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses(2017)131 cited
- → Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase⊥⊥ Atomic coordinates and structure factors for crystal structure of compound3dwith p38α can be accessed using PDB code 3LHJ.(2010)30 cited
- → Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice(1999)19 cited
- → The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice.(1994)11 cited
- → Impact of Disease Burden, CAR-T Expansion, and Mononuclear Cell Recovery on Overall Response and Duration of Response in Zuma-3 Pivotal Study(2024)